Literature DB >> 21686079

Stem cell therapy for glaucoma: possibilities and practicalities.

Thomas V Johnson1, Natalie D Bull, Keith R Martin.   

Abstract

Glaucoma is a progressive, neurodegenerative, optic neuropathy in which currently available therapies cannot always prevent, and do not reverse, vision loss. Stem cell transplantation may provide a promising new avenue for treating many presently incurable degenerative conditions, including glaucoma. This article will explore the various ways in which transplantation of stem or progenitor cells may be applied for the treatment of glaucoma. We will critically discuss the translational prospects of two cell transplantation-based treatment modalities: neuroprotection and retinal ganglion cell replacement. In addition, we will identify specific questions that need to be addressed and obstacles to overcome on the path to clinical translation, and offer insight into potential strategies for approaching this goal.

Entities:  

Year:  2011        PMID: 21686079      PMCID: PMC3114633          DOI: 10.1586/eop.11.3

Source DB:  PubMed          Journal:  Expert Rev Ophthalmol        ISSN: 1746-9899


  104 in total

1.  Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation.

Authors:  Dietmar Fischer; Victoria Petkova; Solon Thanos; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres.

Authors:  M S Ward; A Khoobehi; E B Lavik; R Langer; M J Young
Journal:  J Pharm Sci       Date:  2007-03       Impact factor: 3.534

3.  Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats.

Authors:  K F So; A J Aguayo
Journal:  Brain Res       Date:  1985-03-04       Impact factor: 3.252

4.  Failure of medical therapy despite normal intraocular pressure.

Authors:  Mark J Walland; Roberto G Carassa; Ivan Goldberg; Franz Grehn; Dale K Heuer; Peng T Khaw; Ravi Thomas; Rajul Parikh
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

5.  Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.

Authors:  H Liu; O Honmou; K Harada; K Nakamura; K Houkin; H Hamada; J D Kocsis
Journal:  Brain       Date:  2006-08-10       Impact factor: 13.501

6.  Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging.

Authors:  N Gupta; G Greenberg; L Noël de Tilly; B Gray; M Polemidiotis; Y H Yücel
Journal:  Br J Ophthalmol       Date:  2008-08-12       Impact factor: 4.638

7.  Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.

Authors:  Simone Iwabe; Norma A Moreno-Mendoza; Francisco Trigo-Tavera; Cheryl Crowder; Gustavo A García-Sánchez
Journal:  Vet Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.644

8.  Engraftment of adult neural progenitor cells transplanted to rat retina injured by transient ischemia.

Authors:  Yan Guo; Peter Saloupis; Steven J Shaw; Dennis W Rickman
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

9.  Fate of multipotent neural precursor cells transplanted into mouse retina selectively depleted of retinal ganglion cells.

Authors:  Carla B Mellough; Qi Cui; Kirsty L Spalding; Natalie A Symons; Margaret A Pollett; Evan Y Snyder; Jeffrey D Macklis; Alan R Harvey
Journal:  Exp Neurol       Date:  2004-03       Impact factor: 5.330

10.  Retinal repair by transplantation of photoreceptor precursors.

Authors:  R E MacLaren; R A Pearson; A MacNeil; R H Douglas; T E Salt; M Akimoto; A Swaroop; J C Sowden; R R Ali
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

View more
  12 in total

1.  BDNF treatment and extended recovery from optic nerve trauma in the cat.

Authors:  Arthur J Weber; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-09       Impact factor: 4.799

Review 2.  Stem cells, retinal ganglion cells and glaucoma.

Authors:  Valentin M Sluch; Donald J Zack
Journal:  Dev Ophthalmol       Date:  2014-04-10

Review 3.  Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale.

Authors:  Lynda S Wright; M Joseph Phillips; Isabel Pinilla; Derek Hei; David M Gamm
Journal:  Exp Eye Res       Date:  2014-02-16       Impact factor: 3.467

Review 4.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

5.  Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo.

Authors:  L Guo; B Davis; S Nizari; E M Normando; H Shi; J Galvao; L Turner; J Shi; M Clements; S Parrinello; M F Cordeiro
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

Review 6.  A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.

Authors:  Anna Cislo-Pakuluk; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

7.  Predegenerated Schwann cells--a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity.

Authors:  Adrian Smedowski; Xiaonan Liu; Marita Pietrucha-Dutczak; Iwona Matuszek; Markku Varjosalo; Joanna Lewin-Kowalik
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

8.  Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant Culture.

Authors:  Thomas V Johnson; Ericka N Oglesby; Matthew R Steinhart; Elizabeth Cone-Kimball; Joan Jefferys; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-01-01       Impact factor: 4.799

Review 9.  Current perspective of neuroprotection and glaucoma.

Authors:  Kailin Tian; Shannon Shibata-Germanos; Milena Pahlitzsch; M Francesca Cordeiro
Journal:  Clin Ophthalmol       Date:  2015-11-11

Review 10.  Cell-Based Therapies for Trabecular Meshwork Regeneration to Treat Glaucoma.

Authors:  Shayshadri Mallick; Malini Sharma; Ajay Kumar; Yiqin Du
Journal:  Biomolecules       Date:  2021-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.